Related Experiment Video

Updated: Aug 25, 2026

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

V599EB-RAF is an oncogene in melanocytes

Claudia Wellbrock1, Lesley Ogilvie, Douglas Hedley

  • 1Signal Transduction Team, Cancer Research UK Centre of Cell and Molecular Biology, The Institute of Cancer Research, London, United Kingdom.

Cancer Research
|April 3, 2004
PubMed

Insights

Oncogenic B-RAF drives early melanoma by activating MEK/ERK signaling. However, this pathway shows redundancy in RAS-transformed cells, impacting future melanoma therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The V599E mutation in B-RAF is prevalent in human melanomas but also found in benign nevi, obscuring its oncogenic role.
  • Understanding B-RAF's function in early melanoma development is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the role of oncogenic V599E B-RAF in the early stages of melanoma.
  • To elucidate the signaling pathways and cellular consequences of V599E B-RAF expression in melanocytes.

Main Methods:

  • Expression of V599E B-RAF in cultured melanocytes.
  • Analysis of mitogen-activated protein kinase (MAPK) pathway signaling (MEK and ERK).
  • Assessment of cell proliferation and tumorigenicity in vivo.

Main Results:

  • V599E B-RAF induced constitutive MEK/ERK signaling, promoting growth independent of external stimuli.
  • Cells expressing V599E B-RAF exhibited tumorigenicity in nude mice.
  • B-RAF depletion did not inhibit MEK-ERK signaling or cell cycle progression in RAS-transformed melanocytes or human melanoma cells with oncogenic RAS, indicating pathway redundancy.

Conclusions:

  • Oncogenic B-RAF acts as a potent driver in early melanoma via MEK/ERK signaling.
  • RAS-mediated signaling bypasses the need for B-RAF in later-stage or RAS-driven melanoma.
  • Therapeutic strategies targeting B-RAF may be less effective in melanomas with RAS pathway activation due to inherent redundancy.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...